Wolverine Trading’s Rockwell Medical RMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,160
Closed -$24.1K 5100
2023
Q3
$24.1K Buy
+1,160
New +$35.2K ﹤0.01% 4299
2021
Q2
Sell
-175
Closed -$21K 6574
2021
Q1
$21K Buy
175
+21
+14% +$3.1K ﹤0.01% 5757
2020
Q4
$17K Sell
154
-74
-32% -$8.29K ﹤0.01% 4700
2020
Q3
$26K Buy
+228
New +$39.5K ﹤0.01% 4369
2020
Q2
Sell
-120
Closed -$26K 5135
2020
Q1
$26K Buy
+120
New +$34.2K ﹤0.01% 4393
2019
Q4
Sell
-121
Closed -$40K 5103
2019
Q3
$40K Sell
121
-273
-69% -$83.9K ﹤0.01% 4089
2019
Q2
$130K Sell
394
-37
-9% -$18.8K ﹤0.01% 3917
2019
Q1
$270K Buy
431
+226
+110% +$103K ﹤0.01% 3490
2018
Q4
$56K Sell
205
-56
-21% -$22.3K ﹤0.01% 4143
2018
Q3
$121K Sell
261
-786
-75% -$381K ﹤0.01% 4466
2018
Q2
$600K Hold
1,047
﹤0.01% 2847
2018
Q1
$600K Buy
1,047
+581
+125% +$367K ﹤0.01% 2847
2017
Q4
$299K Buy
466
+63
+16% +$44.4K ﹤0.01% 3632
2017
Q3
$379K Buy
+403
New +$308K ﹤0.01% 2949
2017
Q2
Sell
-384
Closed -$259K 4857
2017
Q1
$259K Sell
384
-799
-68% -$527K ﹤0.01% 3205
2016
Q4
$852K Buy
1,183
+609
+106% +$421K ﹤0.01% 2068
2016
Q3
$408K Buy
+574
New +$465K ﹤0.01% 2823

Other funds holding RMTI

Wolverine Trading's RMTI Position: Q1 2022 in Review

Wolverine Trading sold out of Rockwell Medical (RMTI) in Q1 2022, closing a stake of 94 shares — an estimated $4K sold.

Wolverine Trading first reported a position in RMTI in Q3 2016 and held it in 15 quarters. The position peaked at $260K in Q3 2017. 58 funds tracked by Wall St. Rank hold RMTI as of Q1 2022.

  • Wolverine Trading reported no remaining Rockwell Medical position as of Q1 2022 after selling out during the quarter.
  • Wolverine Trading sold 94 Rockwell Medical shares in Q1 2022, an estimated $4K.
  • Wolverine Trading first reported a position in Rockwell Medical in Q3 2016 and held it in 15 quarters.
  • Wolverine Trading's Rockwell Medical position peaked at $260K in Q3 2017.
  • 58 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2022.

Based on Wolverine Trading's 13F filing for Q1 2022, filed 16 May 2022.